This choice, unlike a phage-antibiotic combination that proved unable to lyse a laboratory PA biofilm [17,18], provides new evidence on identical increased activity of phage-MPM and phage-TOB combinations in reducing CF PA biofilms. The gene discussed is MTLN; the disease is cystic fibrosis.